Taisho Pharmaceutical Holdings Co., Ltd. (4581.T)

Home
4581.T
Financials

8580 (JPY) • At close April 8, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1	2014 Q4	2014 Q3	2014 Q2	2014 Q1	2013 Q4	2013 Q3	2013 Q2	2013 Q1	2012 Q4	2012 Q3	2012 Q2	2012 Q1	2011 Q4	2011 Q3	2011 Q2	2011 Q1	2010 Q4	2010 Q3	2010 Q2	2010 Q1	2009 Q4	2009 Q3	2009 Q2	2009 Q1	2008 Q4	2008 Q3	2008 Q2
Revenue Numbers are in millions	83,576	82,295	80,802	73,712	83,151	75,449	69,069	68,152	69,890	66,277	63,884	67,844	68,249	70,878	75,066	77,292	79,108	71,978	60,342	61,441	70,364	67,722	61,842	64,856	77,302	69,447	68,533	63,400	75,370	71,539	69,441	65,556	78,702	76,538	69,160	68,895	79,775	73,401	68,418	68,158	83,230	76,430	68,151	64,942	80,276	72,176	67,720	60,083	77,932	68,898	64,332	61,036	74,587	68,482	64,592	55,711	73,081	66,113	63,612	56,580	73,342	64,482
Cost of Revenue Numbers are in millions	37,096	35,380	32,522	32,222	33,124	30,921	27,264	26,525	26,209	27,493	24,144	28,527	25,154	24,532	27,837	31,249	32,705	25,346	19,037	22,097	24,848	22,966	21,295	22,571	26,162	24,189	24,232	23,541	27,337	25,615	25,032	25,130	31,420	29,898	26,695	27,702	31,430	27,992	25,116	26,411	30,963	28,381	25,520	25,550	30,920	27,275	25,159	22,543	28,183	25,115	23,157	23,171	26,126	24,053	23,108	20,756	25,831	23,082	22,146	20,409	25,043	21,582
Gross Profit Numbers are in millions	46,480	46,915	48,280	41,490	50,027	44,528	41,805	41,627	43,681	38,784	39,740	39,317	43,095	46,346	47,229	46,043	46,403	46,632	41,305	39,344	45,516	44,756	40,547	42,285	51,140	45,258	44,301	39,859	48,033	45,924	44,409	40,426	47,282	46,640	42,465	41,193	48,345	45,409	43,302	41,747	52,267	48,049	42,631	39,392	49,356	44,901	42,561	37,540	49,749	43,783	41,175	37,865	48,461	44,429	41,484	34,955	47,250	43,031	41,466	36,171	48,299	42,900
Gross Profit Ratio Numbers are in millions	0.556	0.57	0.598	0.563	0.602	0.59	0.605	0.611	0.625	0.585	0.622	0.58	0.631	0.654	0.629	0.596	0.587	0.648	0.685	0.64	0.647	0.661	0.656	0.652	0.662	0.652	0.646	0.629	0.637	0.642	0.64	0.617	0.601	0.609	0.614	0.598	0.606	0.619	0.633	0.613	0.628	0.629	0.626	0.607	0.615	0.622	0.628	0.625	0.638	0.635	0.64	0.62	0.65	0.649	0.642	0.627	0.647	0.651	0.652	0.639	0.659	0.665
Reseach & Development Expenses Numbers are in millions	5,786	5,067	4,710	6,106	5,018	4,791	4,812	19,366	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	0	0	0	-13,966	0	0	0	-32,753	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	49,456	0	0	0	51,404	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	38,037	34,561	39,206	35,490	34,091	32,785	36,550	18,651	38,861	39,147	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Expenses Numbers are in millions	198	46	-29	122	94	46	60	25	-261	105	-5	-268	26	339	238	-31	60	90	51	117	142	347	497	106	226	134	168	146	174	140	146	149	186	81	270	159	150	146	203	90	163	133	205	195	-231	197	658	45	655	55	727	-109	454	224	676	79	593	2	503	537	673	46
Operating Expenses Numbers are in millions	43,823	39,628	39,206	41,596	39,109	37,576	36,550	38,017	38,861	39,147	37,063	40,216	38,526	39,441	37,838	42,153	43,510	40,279	32,981	36,248	34,393	35,921	32,389	33,864	37,763	37,022	37,358	34,456	38,126	38,376	35,302	34,270	38,485	37,951	37,229	34,054	39,741	37,785	34,693	36,531	37,308	35,588	33,582	34,851	38,107	35,163	32,752	34,453	34,720	34,336	30,324	34,074	32,829	31,717	29,560	29,515	36,203	31,090	35,209	30,715	35,302	35,090
Operating Income Numbers are in millions	2,657	7,287	9,073	-106	10,917	6,953	5,254	3,610	4,820	-363	2,676	-899	4,569	6,906	9,389	3,891	2,893	6,352	8,324	3,095	11,125	8,834	8,157	8,422	13,377	8,237	6,941	5,406	9,905	7,549	9,106	6,156	8,797	8,691	5,234	7,139	8,604	7,624	8,607	5,215	14,959	12,462	9,047	4,542	11,249	9,738	9,809	3,087	15,029	9,447	10,851	3,791	15,632	12,712	11,924	5,440	11,047	11,941	6,257	5,456	12,997	7,810
Operating Income Ratio Numbers are in millions	0.032	0.089	0.112	-0.001	0.131	0.092	0.076	0.053	0.069	-0.005	0.042	-0.013	0.067	0.097	0.125	0.05	0.037	0.088	0.138	0.05	0.158	0.13	0.132	0.13	0.173	0.119	0.101	0.085	0.131	0.106	0.131	0.094	0.112	0.114	0.076	0.104	0.108	0.104	0.126	0.077	0.18	0.163	0.133	0.07	0.14	0.135	0.145	0.051	0.193	0.137	0.169	0.062	0.21	0.186	0.185	0.098	0.151	0.181	0.098	0.096	0.177	0.121
Total Other Income Expenses Net Numbers are in millions	1,807	-1,363	-1,977	-296	1,709	1,111	3,954	2,276	4,424	2,627	1,328	-287	1,201	669	1,428	63	2,511	861	5,416	-4,853	1,636	32,444	4,045	-35	7,736	805	2,587	1,590	4,644	2,524	1,232	652	2,622	1,491	2,166	1,522	2,641	1,944	2,080	2,210	3,266	1,686	2,470	2,795	3,003	-336	2,409	2,704	759	-1,205	2,320	5,654	1,121	1,180	992	568	-76	-181	794	264	-297	-12,734
Income Before Tax Numbers are in millions	4,464	5,924	7,098	-402	12,626	8,064	9,210	5,885	9,244	2,265	4,004	-1,186	5,769	7,575	10,818	3,954	5,403	7,214	13,740	-1,758	12,762	41,277	12,203	8,387	21,112	9,042	9,529	6,995	14,550	10,072	10,339	6,808	11,418	10,182	7,401	8,661	11,245	9,568	10,688	7,426	18,225	14,147	11,518	7,336	14,252	9,402	12,218	5,791	15,788	8,242	13,171	9,445	16,753	13,892	12,916	6,008	10,971	11,760	7,051	5,720	12,700	-4,924
Income Before Tax Ratio Numbers are in millions	0.053	0.072	0.088	-0.005	0.152	0.107	0.133	0.086	0.132	0.034	0.063	-0.017	0.085	0.107	0.144	0.051	0.068	0.1	0.228	-0.029	0.181	0.61	0.197	0.129	0.273	0.13	0.139	0.11	0.193	0.141	0.149	0.104	0.145	0.133	0.107	0.126	0.141	0.13	0.156	0.109	0.219	0.185	0.169	0.113	0.178	0.13	0.18	0.096	0.203	0.12	0.205	0.155	0.225	0.203	0.2	0.108	0.15	0.178	0.111	0.101	0.173	-0.076
Income Tax Expense Numbers are in millions	1,164	2,238	1,793	972	1,940	2,388	2,896	1,378	2,750	19	2,301	-479	2,278	1,853	4,130	999	1,740	3,270	2,414	796	3,488	12,263	-1,889	2,702	6,118	2,403	3,478	1,891	3,851	3,162	2,846	2,950	3,475	3,148	2,354	3,630	3,651	3,311	3,510	2,626	6,196	4,686	3,797	2,677	4,647	4,022	4,284	1,782	7,602	3,418	4,938	534	6,577	5,278	4,823	2,370	5,103	4,666	3,041	1,450	6,338	3,592
Net Income Numbers are in millions	2,873	3,087	4,363	-1,902	10,022	5,126	5,751	4,148	6,066	1,729	1,179	-919	2,941	5,230	6,064	2,602	2,950	3,973	11,006	-2,805	8,964	28,745	13,689	5,216	14,447	6,482	5,534	5,111	10,171	6,554	6,945	3,768	7,424	6,595	4,686	4,888	7,047	5,935	6,658	4,853	11,323	9,106	7,410	4,472	9,182	5,075	7,591	3,760	7,801	4,744	8,052	8,946	9,726	8,510	7,708	3,711	5,410	6,784	3,580	4,120	5,748	-8,747
Net Income Ratio Numbers are in millions	0.034	0.038	0.054	-0.026	0.121	0.068	0.083	0.061	0.087	0.026	0.018	-0.014	0.043	0.074	0.081	0.034	0.037	0.055	0.182	-0.046	0.127	0.424	0.221	0.08	0.187	0.093	0.081	0.081	0.135	0.092	0.1	0.057	0.094	0.086	0.068	0.071	0.088	0.081	0.097	0.071	0.136	0.119	0.109	0.069	0.114	0.07	0.112	0.063	0.1	0.069	0.125	0.147	0.13	0.124	0.119	0.067	0.074	0.103	0.056	0.073	0.078	-0.136
EPS Numbers are in millions	35.05	37.66	53.22	-23.2	122.25	62.53	70.15	50.6	74.48	21.17	14.77	-11.51	36.85	65.53	75.98	32.6	36.96	49.78	137.91	-35.14	112.31	360.12	171.5	65.35	180.99	81.12	69.27	63.96	127.29	82.02	86.92	47.15	92.91	81.36	57.81	60.3	86.93	73.21	82.13	59.86	139.67	112.29	91.38	55.15	113.23	63.14	94.44	46.78	97.05	57.34	97.33	108.12	113.8	99.57	91.37	43.42	62.33	78.16	41.24	47.47	59.79	-105.72
EPS Diluted Numbers are in millions	35	37.6	53.15	-23.2	122.09	62.44	70.08	50.54	74.4	21.15	14.75	-11.51	36.85	65.53	75.89	32.6	36.96	49.78	137.77	-35.14	112.31	360.12	171.35	65.35	180.99	81.12	69.21	63.96	127.29	82.02	86.86	47.15	92.91	81.36	57.78	60.3	86.93	73.21	82.1	59.86	139.67	112.29	91.36	55.15	113.23	63.14	94.44	46.78	97.05	57.34	97.33	108.12	113.8	99.57	91.37	43.42	62.33	78.16	41.24	47.47	59.79	-97.96
EBITDA Numbers are in millions	4,723	8,030	11,173	1,325	11,879	8,160	9,274	6,979	7,324	226	4,053	1,310	5,918	7,776	11,147	4,124	6,014	7,341	7,650	4,686	13,454	10,506	12,205	8,762	15,531	9,054	8,796	6,660	12,247	8,709	10,421	7,677	11,418	10,187	7,494	8,686	11,304	8,814	10,773	7,428	18,242	14,092	11,485	6,248	14,262	11,505	12,174	5,807	16,950	10,895	12,559	13,668	19,898	16,981	15,966	9,392	14,958	14,491	9,670	8,954	16,238	8,376
EBITDA Ratio Numbers are in millions	0.057	0.098	0.138	0.018	0.143	0.108	0.134	0.102	0.105	0.003	0.063	0.019	0.087	0.11	0.148	0.053	0.076	0.102	0.127	0.076	0.191	0.155	0.197	0.135	0.201	0.13	0.128	0.105	0.162	0.122	0.15	0.117	0.145	0.133	0.108	0.126	0.142	0.12	0.157	0.109	0.219	0.184	0.169	0.096	0.178	0.159	0.18	0.097	0.217	0.158	0.195	0.224	0.267	0.248	0.247	0.169	0.205	0.219	0.152	0.158	0.221	0.13

Taisho Pharmaceutical Holdings Co., Ltd.

TSE:4581.T Add to watchlist

TSE:4581.T